Improvement of the in vitro dissolution of praziquantel by complexation with α-, β- and γ-cyclodextrins
- 8 March 1999
- journal article
- research article
- Published by Elsevier
- Vol. 179 (1) , 65-71
- https://doi.org/10.1016/s0378-5173(98)00382-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Molecular Complexation: β-Cyclodextrin and Benzaldehyde Inclusion ComplexPharmaceutical Research, 1992
- Cyclodextrins in the Pharmaceutical FieldDrug Development and Industrial Pharmacy, 1991
- Improvement of the in vitro dissolution characteristics of famotidine by inclusion in β-cyclodextrinInternational Journal of Pharmaceutics, 1990
- Pharmaceutical Uses of Cyclodextrins and DerivativesDrug Development and Industrial Pharmacy, 1990
- Characterization, Dissolution and Diffusion Properties of Tolbutamide-β-Cyclodextrin Complex SystemDrug Development and Industrial Pharmacy, 1988
- The acetotoluides as models for studying cyclodextrin inclusion complexesInternational Journal of Pharmaceutics, 1987
- Praziquantel: mechanisms of anti-schistosomal activityPharmacology & Therapeutics, 1985
- Mechanism of drug dissolution rate enhancement from β-cyclodextrin-drug systemsJournal of Pharmacy and Pharmacology, 1982
- Estimation of Dissolution Rate of Salicylamide in Complexing Media Using a Theoretical Diffusion ModelJournal of Pharmaceutical Sciences, 1978
- Interactions of .ALPHA.- and .BETA.-cyclodextrin with several non-steroidal antiinflammatory drugs in aqueou solution.CHEMICAL & PHARMACEUTICAL BULLETIN, 1975